These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28408066)

  • 1. Derivation and Validation of a Scoring System for Intravenous Tissue Plasminogen Activator Use in Asian Patients.
    Yeo LLL; Chien SC; Lin JR; Liow CW; Lee JD; Peng TI; Luen TH; Sharma V; Chan B; Lee TH;
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1695-1703. PubMed ID: 28408066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G; Demchuk A; Tu JV; Johnston SC;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients.
    Park TH; Park SS; Ko Y; Lee SJ; Lee KB; Lee J; Kang K; Park JM; Choi JC; Kim DE; Cho YJ; Hong KS; Kim JT; Kim DH; Cha JK; Han MK; Lee JS; Lee J; Yu KH; Lee BC; Yoon BW; Bae HJ; Saposnik G
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):367-73. PubMed ID: 23800501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Wong LY; Ong BK; Chan BP; Teoh HL
    J Stroke Cerebrovasc Dis; 2010; 19(6):424-30. PubMed ID: 20554224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
    Ali-Ahmed F; Federspiel JJ; Liang L; Xu H; Sevilis T; Hernandez AF; Kosinski AS; Prvu Bettger J; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005609. PubMed ID: 31412730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intravenous thrombolysis for ischaemic stroke in Asian octogenarians and nonagenarians.
    Sun MC; Lai TB; Jeng JS; Sung SF; Sung PS; Tang SC; Chen WL; Chen CH
    Age Ageing; 2015 Jan; 44(1):158-61. PubMed ID: 25355619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams.
    Scott PA; Frederiksen SM; Kalbfleisch JD; Xu Z; Meurer WJ; Caveney AF; Sandretto A; Holden AB; Haan MN; Hoeffner EG; Ansari SA; Lambert DP; Jaggi M; Barsan WG; Silbergleit R
    Acad Emerg Med; 2010 Oct; 17(10):1062-71. PubMed ID: 21040107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAcial Disparities in Ich after IV-tPA and Neurointerventional Treatment (RADIANT).
    Chiang CC; Meyer DM; Meyer BC; Agrawal K; Modir R
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104474. PubMed ID: 31784381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X; George MG; Yang Q; Gillespie C
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
    Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.